Foritinib Impurity 14 CAS CATO-C4X-331014
| CAS No. | CATO-C4X-331014 |
| Molecular Formula | C15H20BrNO3 |
| Molecular Weight | 342.23 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
Foritinib Impurity 14 (CAS CATO-C4X-331014) is a certified pharmaceutical impurity reference standard with the molecular formula C15H20BrNO3 and a molecular weight of 342.23 g/mol.
Structurally, Foritinib Impurity 14 (C15H20BrNO3) contains a nitrogen-containing heterocyclic scaffold, an amide group, a hydroxyl group, an ether linkage, bromine substitution. The molecule exhibits a degree of unsaturation (DBE) of 6.0, corresponding to approximately 6 ring(s) or double-bond equivalent(s). With a molecular weight of 342.23 g/mol, it falls into the moderately-high-molecular-weight range. Halogen substitution (F/Cl/Br/I) produces a distinctive isotope pattern in mass spectrometry, a valuable aid for qualitative confirmation.
Recommended for quantitative analysis by HPLC, GC, LC-MS/MS, or GC-MS as an external calibration standard; it can also be used for spiked-recovery experiments, LOD/LOQ determination, and LC-MS/MS multiple-reaction-monitoring (MRM) calibration.
CATO manufactures Foritinib Impurity 14 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C15H20BrNO3 |
| Molecular Weight | 342.23 g/mol |
| Appearance | Off-white to pale yellow crystalline powder. (slight halide-like odor) |
| Purity | 97%+ |
| Storage | Store at 2-8°C, protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in chloroform, dichloromethane, ethyl acetate, DMSO |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 6.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| Halogen Content | Br-containing |
| Nitrogen Atoms | 1 |
Related Foritinib Standards
- Foritinib Impurity 13 (CAS CATO-C4X-331013)
- Foritinib Impurity 5 (CAS CATO-C4X-33105)
- Foritinib Impurity 9 (CAS CATO-C4X-33109)
- Foritinib Impurity 1 (CAS CATO-C4X-33101)
- Foritinib Impurity 8 (CAS CATO-C4X-33108)
- Foritinib Impurity 17 (CAS CATO-C4X-331017)
- Foritinib Impurity 2 (CAS CATO-C4X-33102)
- Foritinib Impurity 16 (CAS CATO-C4X-331016)
Recommended Standards
- Palbociclib Impurity 4 (CAS 1774897-13-0)
- Palbociclib Impurity 3 (CAS 153747-97-8)
- 1-(4-Methoxy-benzyl)-3,5-dimethyl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-1H-pyrazole (CAS 1232027-73-4)
- Palbociclib Impurity 114 (CAS 412348-27-7)
- Obeticholic Acid Impurity 32 (CAS CATO-C4X-115332)
- Pazopanib Impurity 65 (CAS CATO-C4X-172565)
- Clenbuterol Impurity 21 (CAS CATO-C4X-199321)
- 3-Pentenenitrile, Pract. (CAS 4635-87-4)
- 4-[2-(2-Methoxyethoxy)ethoxy]-2-methylphenylamine (CAS 329946-04-5)
- 4-Ethoxy-2-(piperazin-1-yl)-7-(pyridin-4-yl)-5H-pyrimido[5,4-b]indole (CAS 1034194-07-4)
- 4-Bromo-2-chloro-1-(methylsulfonyl)benzene (CAS 648905-09-3)
- 14069-13-7 4173AD 5-(2-Pyrrolidin-1-yl-ethyl)-[1,3,4]thiadiazol-2-ylamine C8H14N4S (CAS 14069-13-7)
- 2-(2-cyano-3-fluoroanilino)ethyl N-(1,2,2-trichlorovinyl)carbamate (CAS 647824-11-1)
- Amyloid Precursor Frameshift Mutant C-Terminal Peptide trifluoroacetate salt (CAS 189125-14-2)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com